Showing 1 - 9 results of 9 for search 'Daisuke Ishikawa', query time: 0.05s
Refine Results
-
1
Sound velocity of hexagonal close-packed iron to the Earth’s inner core pressure by Daijo Ikuta, Eiji Ohtani, Hiroshi Fukui, Takeshi Sakai, Daisuke Ishikawa, Alfred Q. R. Baron
Published 2022-11-01
Article -
2
-
3
-
4
IgG4-related hypothalamo-hypophysitis by Yuki Urushida, Daisuke Ishikawa, Mayuri Yanaizumi, Takumi Nakamura, Masakuni Amari, Takeshi Kawarabayashi, Masahiko Tosaka, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji
Published 2021-09-01
Article -
5
Ability of the Met kinase inhibitor crizotinib and new generation EGFR inhibitors to overcome resistance to EGFR inhibitors. by Shigeki Nanjo, Tadaaki Yamada, Hiroshi Nishihara, Shinji Takeuchi, Takako Sano, Takayuki Nakagawa, Daisuke Ishikawa, Lu Zhao, Hiromichi Ebi, Kazuo Yasumoto, Kunio Matsumoto, Seiji Yano
Published 2013-01-01
Article -
6
mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGF. by Daisuke Ishikawa, Shinji Takeuchi, Takayuki Nakagawa, Takako Sano, Junya Nakade, Shigeki Nanjo, Tadaaki Yamada, Hiromichi Ebi, Lu Zhao, Kazuo Yasumoto, Takahiro Nakamura, Kunio Matsumoto, Hiroshi Kagamu, Hirohisa Yoshizawa, Seiji Yano
Published 2013-01-01
Article -
7
Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system by Naoki Yoshioka, Akihiko Okumura, Yukie Yamamoto, Katsura Yamaguchi, Atsuro Kaga, Kentaro Yamada, Takuya Hirosaki, Daisuke Ishikawa, Shin Kunii, Kazumasa Watanabe, Setsuo Utsunomiya, Kazuhiko Hayashi, Masatoshi Ishigami, Hidemi Goto, Yoshiki Hirooka
Published 2017-05-01
Article -
8
Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC by Kenichi Koyama, Satoru Miura, Satoshi Watanabe, Satoshi Shoji, Jun Koshio, Yoshiki Hayashi, Daisuke Ishikawa, Ko Sato, Takao Miyabayashi, Masaaki Okajima, Takeshi Ota, Tomohiro Tanaka, Naoya Matsumoto, Hideyuki Kuriyama, Tetsuya Abe, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Hiroshi Tanaka, Toshiaki Kikuchi
Published 2022-04-01
Article -
9
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory <i>ALK</i>-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501) by Satoshi Watanabe, Kazuko Sakai, Naoya Matsumoto, Jun Koshio, Akira Ishida, Tetsuya Abe, Daisuke Ishikawa, Tomohiro Tanaka, Ami Aoki, Tomosue Kajiwara, Kenichi Koyama, Satoru Miura, Yuka Goto, Tomoki Sekiya, Ryo Suzuki, Kohei Kushiro, Toshiya Fujisaki, Naohiro Yanagimura, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Yu Saida, Hirohisa Yoshizawa, Kazuto Nishio, Toshiaki Kikuchi
Published 2022-12-01
Article